Towards selective DNA targeting: synthesis of an antibody–macrocycle–intercalator conjugate
Abstract
The synthesis is reported of a trivalent conjugate incorporating a macrocyclic bifunctional complexing agent, an engineered human monoclonal antibody fragment and an established DNA intercalator.